Delivery Order SPE2DB22D1017-SPE2DB23FG1TR
Award Date 8/16/23
Potential Completion Date 8/17/23
Potential Value $5.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,190 to Amerisourcebergen Drug Corporation for 4562055135 Vyvanse 30 mg capsules (100 count). The place of performance is Amerisourcebergen's corporate office and distribution center located in Conshohocken, Pennsylvania. The period of performance is September 5-6, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for Vyvanse, a...
- The Defense Logistics Agency awarded a $3,017 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of Vyvanse 10 mg. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 14, 2023. Vyvanse, a Schedule II controlled substance, is used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply...
- The Defense Logistics Agency awarded a $431,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 Vyvanse 40mg capsules. Vyvanse is a medication used to treat attention deficit hyperactivity disorder and binge eating disorder. The place of performance for this order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. No subcontractors or set aside designations were...
- Defense Logistics Agency awarded a $11,853.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 10 mg Vyvanse to be delivered by October 20, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No set-aside provisions were applied to this contract action. Vyvanse is a prescription medication used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,814 to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was issued under an...
- The Defense Logistics Agency Troop Support Medical awarded a $23,705.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562138157 Vyvanse capsules 50mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from September 12, 2023 to September 13, 2023. No major subcontractors or set aside designations were indicated. This delivery order appears to be fulfilling a...
- The Defense Logistics Agency awarded a $2,667 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of Vyvanse 20 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. This order was placed under an existing Amerisourcebergen contract vehicle to supply pharmaceutical products and...
- The Defense Logistics Agency awarded a $2,586.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the 30 mg Vyvanse medication. The delivery order was issued under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding on August 29, 2023. The purpose of this order is to provide Vyvanse, a Schedule II...
- The Defense Logistics Agency awarded a $3,401.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 30 mg Vyvanse. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The one-day order runs from August 2 to August 3, 2023 to supply the attention deficit hyperactivity disorder medication to support DLA requirements. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products through its corporate...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,922 to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is August 22-23, 2023. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. The Defense Logistics Agency manages the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG1TRDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,076 to Amerisourcebergen Drug Corporation for the supply of 100 Vyvanse 30 mg capsules. The place of performance for this order is Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. This delivery order was issued against an existing DLA pharmaceutical supply contract vehicle to fulfill requirements for Vyvanse, a Schedule II prescription stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. No set aside designation or subcontracting details were provided.
Generated 12/14/23, 9:48 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/16/23 |